← Browse by Condition
Medical Condition
parkinson s disease pd
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 2, Phase 3, EARLY_Phase 1
ClinicalMetric tracks all active clinical trials for parkinson s disease pd sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — parkinson s disease pd Clinical Trials
How many clinical trials are currently recruiting for parkinson s disease pd?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for parkinson s disease pd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for parkinson s disease pd?
parkinson s disease pd research spans Phase 1 (2 trials), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a parkinson s disease pd clinical trial?
Eligibility criteria for parkinson s disease pd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 2
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07610369 Phase 2
Recruiting
Enrollment
40 pts
Location
United States
Sponsor
Yale University
NCT07455760
Recruiting
Enrollment
80 pts
Location
United States
Sponsor
Boston University Charles Rive...
NCT07284784 Phase 2, Phase 3
Recruiting
Enrollment
500 pts
Location
United States
Sponsor
Annovis Bio Inc.
NCT06891703 EARLY_Phase 1
Recruiting
Enrollment
46 pts
Location
Sweden
Sponsor
AC Immune SA
NCT07170475 Phase 1
Recruiting
Enrollment
24 pts
Location
Japan
Sponsor
Fujita Health University
NCT03402919
Recruiting
Enrollment
1,573 pts
Location
Canada
Sponsor
McGill University
NCT07336199
Recruiting
Enrollment
25 pts
Location
Germany
Sponsor
Ludwig-Maximilians - Universit...
NCT07568951
Recruiting
Enrollment
210 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT07790744
Recruiting
Enrollment
100 pts
Location
Denmark
Sponsor
Danish Research Centre for Mag...
NCT07774312
Recruiting
Enrollment
60 pts
Location
China
Sponsor
Ruijin Hospital
Related Conditions
depression (1) essential tremor (1) deep brain stimulation (1) multiple system atrophy msa (1) dementia with lewy bodies dlb (1) dementia (1) mild cognitive impairment mci (1) subjective cognitive impairment (1) lewy body disease lbd (1) mixed dementia (1) frontotemporal dementia ftd (1) alzheimer disease ad (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology